Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation
Abstract In heart failure (HF), energy metabolism pathway in cardiac muscle changes from fatty acid β-oxidation to glycolysis. However, the exact mechanism is unknown. Sarcoendoplasmic reticulum Ca2+α ATPase (SERCA) expression is downregulated and mitochondrial function is reduced in HF, perhaps par...
Guardado en:
Autores principales: | Zhiwei Dong, Pei Zhao, Ming Xu, Chen Zhang, Wei Guo, Huihua Chen, Jing Tian, Hongchang Wei, Rong lu, Tongtong Cao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6c1867536f84fb8b650e16dd272b5e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
por: Yan-Bo Sui, et al.
Publicado: (2019) -
Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
por: Liang XY, et al.
Publicado: (2021) -
Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Wei Liu, et al.
Publicado: (2019) -
Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
por: Xianhui Kang, et al.
Publicado: (2021) -
Bistability in glycolysis pathway as a physiological switch in energy metabolism.
por: Bhanu Chandra Mulukutla, et al.
Publicado: (2014)